No Detail Found!

A 6-lncRNA Signature to Improve Prognostic Prediction of Colon Cancer

Author(s)
Wang Yuhang Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing- China.
Chen Lu Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing , China
Pei Lixia Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing , China
Chen Yufeng Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing , China
Hu Yue Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing , China
Hou Wenzhen Department, Nanjing University of Traditional Chinese Medicine, Nanjing , China
Song Yafang Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing , China.
Sun Mengzhu Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing , China.
Sun Jianhua Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing , China.
Abstract
Background and Objective: Colorectal cancer is one of the most common malignant tumors in the world. The prognosis of colorectal cancer is thus variable despite the rapid development of treatment methods in recent years, the prognosis of colorectal cancer is still not satisfactory. Therefore, it is important to understand pathogenesis and development for more accurate prognostic methods. The present study aimed to identify a long non-coding (lnc) RNAs-based signature for prognosis in colon cancer patients. Methods: Datasets from the GEO and TCGA databases were used, differential expression of lncRNA was analyzed, and a 6-lncRNA signature was identified. KEGG and GO was used to enrich the signal pathway to determine the biological effects of these 6-lncRNA. Results: This study has established a prognosis model containing “LINC01494”, “TRPM2-AS”, “ATP1A1-AS1”, “FRY-AS1”, “LINC01360”, and “RBFADN” based on data set of colorectal cancer patients available in the TCGA and GEO databases. The prognostic model of lncRNAs can predict the prognosis of patients with colorectal cancer. Conclusion: The present study identified a 6-lncRNA signature that could predict the survival rate for colon cancer patients.
Publication Details
Page(s) 29-38
Published Journal: Biomedica, Volume: 37, Issue: 1, Year: 2021

Request the full text from PASTIC

Keywords
Long non-coding (lnc) RNA, Colon cancer, Bioinformatics, Signature
References
Nappi A,Berretta M,Romano C,Tafuto S,Cassata A,Casaretti R .2018 .Metastatic colorectal cancer: role of target therapies and future perspectives. Curr Cancer Drug Targets, 18(5) : 421-9.
Binnebosel M,Lambertz A,Dejong K,Neumann UP .2018 .Oligometastasized colorectal cancer-modern treatment strategies. Chirurg, 89(7) : 497-504.
McMillan DC,Wotherspoon HA,Fearon KC,Sturgeon C,Cooke TG,McArdle CS .1995 .A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg, 9610(99) : 6-7.
Mahar AL,Compton C,Halabi S,Hess KR,Weiser MR,Groome PA .2017 .Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes. J Surg Oncol, 116(8) : 969-82.
Campisi J .2013 .Aging, cellular senescence, and cancer. Annu Rev Physiol, 030 : 212-183653.
Gutschner T,Diederichs S. .2012 .The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol, 9(6) : 703-19.
Kopp F,Mendell JT .2018 .Functional classification and experimental dissection of long noncoding RNAs. Cell, 01(3) : 393-407.
Quinn JJ,Chang HY .2015 .Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet, 10(1) : 47-62.
Bhan A,Soleimani M .2017 .Mandal SS. Long noncoding Rna and cancer: A new paradigm. Cancer Res, 16(15) : 0008-5472.
Peng WX,Koirala P,Mo YY .2017 .LncRNA-mediated regulation of cell signaling in cancer. Oncogene, 184(41) : 5661-7.
Bartonicek N,Maag JL,Dinger ME .2016 .Long noncoding RNAs in cancer: mechanisms of action and technological advancements. Mol Cancer, 15(1) : 43.
Qiu MT,Hu JW,Yin R,Xu L .2013 .Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol, 34(2) : 613-20.
Xu S,Sui S,Zhang J,Bai N,Shi Q,Zhang G .2015 .Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer. Int J Clin Exp Pathol, 8(5) : 4881-91.
Ji Q,Liu X,Fu X,Zhang L,Sui H,Zhou L .2013 .: e78700. PLoS One, 8(11) : .
Bolha L,Ravnik-Glavac M .2017 .Glavac D. Long noncoding RNAs as biomarkers in cancer. Dis Markers, : 7243968.
Fattahi S,Kosari-Monfared M,Golpour M,Emami Z,Ghasemiyan M,Nouri M .2020 .LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine. J Cell Physiol, 235(4) : 3189-206.
Dastmalchi N,Safaralizadeh R,Nargesi MM .2020 .LncRNAs: Potential novel prognostic and diagnostic biomarkers in colorectal cancer. Curr Med Chem, 27(30) : 5067-77.
Marmol I,Sanchez-de-Diego C,Pradilla Dieste A,Cerrada E .2017 .Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci, 18(1) : 197-202.
Li X,Cao Y,Gong X,Li H. .2017 .Long noncoding RNAs in head and neck cancer. Oncotarget, 8(6) : 10726-40.
Abbastabar M,Sarfi M,Golestani A,Khalili E. .2018 .lncRNA involvement in hepatocellular carcinoma metastasis and prognosis. EXCLI J, 17(3) : 1541-13.
Li C,Chen J,Zhang K,Feng B,Wang R .2015 .Progress and prospects of long noncoding RNAs (lncrnas) in hepatocellular carcinoma. Cell Physiol Biochem, 36(2) : 423-34.
Kulasingam V,Diamandis EP .2008 .Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol, 5(10) : 588-99.
Sun C,Yuan Q,Wu D,Meng X,Wang B .2017 .Identification of core genes and outcome in gastric cancer using bioinformatics analysis. Oncotarget, 8(41) : 70271-80.
Lian P,Wang Q,Zhao Y,Chen C,Sun X,Li H .2019 .An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer. Aging (Albany NY), 11(17) : 6930-40.
Tang J,Ren J,Cui Q,Zhang D,Kong D,Liao X .2019 .A prognostic 10-lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients. J Cell Mol Med, 23(10) : 6775-84.
Jiang W,Guo Q,Wang C,Zhu Y. .2019 .A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma. Cancer Cell Int, 19 : 208.
Miao R,Ge C,Zhang X,He Y,Ma X,Xiang X .2019 .Combined eight-long noncoding RNA signature: a new risk score predicting prognosis in elderly non-small cell lung cancer patients. Aging (Albany NY), 11(2) : 467-79.
Bray F,Ferlay J,Soerjomataram I,Siegel RL,Torre LA,Jemal A .2018 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 68(6) : 394-424.
Benson AB,Venook AP,Cederquist L,Chan E,Chen YJ,Cooper HS,NCCN HS .2017 .Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 15(3) : 370-98.
Kita Y,Yonemori K,Osako Y,Baba K,Mori S,Maemura K .2016 .Noncoding RNA and colorectal cancer: its epigenetic role. J Hum Genet, 66(1) : 41-7.
Weng M,Wu D,Yang C,Peng H,Wang G,Wang T .2016 .Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer. Transl Res, 10(3) : 108-20.
Huang B,Chang C,Wang BL,Li H .2019 .-induced upregulation of lncRNA TRPM2-AS promotes tumor progression in gastric cancer by regulating miR-195/ HMGA1 axis. J Cell Biochem, 120(10) : 16921-33.
Lavorgna G,Chiacchiera F,Briganti A,Montorsi F,Pasini D,Salonia A .2014 .Expression-profiling of apoptosis induced by ablation of the long ncRNA TRPM2-AS in prostate cancer cell. Genom Data, 10 : 4-5.
Xu C,Huang Q,Zhang C,Xu W,Xu G,Zhao X .2018 .Long non-coding RNA TRPM2-AS as a potential biomarker for hepatocellular carcinoma. Ir J Med Sci, 187(3) : 621-8.
Fan X,Ashraf UM,Drummond CA,Shi H,Zhang X,Kumarasamy S .2018 .Characterization of a long non-coding RNA, the antisense RNA of Na/K-ATPase alpha1 in human kidney cells. Int J Mol Sci, 19(7) : .
Holst MR,Vidal-Quadras M,Larsson E,Song J,Hubert M,Blomberg J .2017 .Clathrin-independent endocytosis suppresses cancer cell blebbing and invasion. Cell Rep, 08(8) : 1893-905.
Kim DH,Wirtz D. .2013 .Focal adhesion size uniquely predicts cell migration. FASEB J, 27(4) : 220160-61.
Wei L,Yin F,Zhang W .2017 .: e6345. Medicine (Baltimore), 96(12) : .
Buhrmann C,Shayan P,Goel A,Shakibaei M. .2017 .Resveratrol regulates colorectal cancer cell invasion by modulation of focal adhesion molecules. Nutrients, 9(10) : 1073-7.
Burridge K. .2017 .Focal adhesions: a personal perspective on a half century of progress. FEBS J, 284(20) : 3355-61.
Li Y,Guo H,Jin C,Qiu C,Gao M,Zhang L .2017 .Spliceosome-associated factor CTNNBL1 promotes proliferation and invasion in ovarian cancer. Exp Cell Res, 05(1) : 124-34.
Hsu TY,Simon LM,Neill NJ,Marcotte R,Sayad A,Bland CS .2015 .The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Nature, 525(7569) : 384-8.
Bonnal S,Vigevani L,Valcarcel J. .2012 .The spliceosome as a target of novel antitumour drugs. Nat Rev Drug Discov, 11(11) : 847-59.
Maury E,Hashizume R .2016 .Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies. Epigenetics, 1278(5) : 353-69.
Audia JE,Campbell RM .2016 .Histone modifications and cancer. Cold Spring Harb Perspect Biol, 8(4) : a019521-7.
Chi P,Allis CD,Wang GG .2010 .Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer, 10(7) : 457-69.
Janke C .2011 .Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions. Nat Rev Mol Cell Biol, 12(12) : 773-86.
0

Citations

0

Downloads

14

Views